WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
Category: #headlines  By Pranali Mehta  Date: 2021-02-17
  • share
  • Twitter
  • Facebook
  • LinkedIn
WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
  • AstraZeneca COVID-19 vaccine has received approval in over 50 countries.
  • AstraZeneca vaccine is the second to be issued by the UN health agency, with Pfizer-BioNTech being the first.

Shares of AstraZeneca plc soared by 6% after the World Health Organization (WHO) reportedly granted a EUA (emergency use authorization) to its COVID-19 vaccine. This move could enable partners of the UN agency to ship millions of doses to economies as part of its global initiative to control the ongoing Coronavirus pandemic.

WHO stated that it would clear the British-Swedish multinational pharmaceutical company vaccines which are being developed by South Korea’s AstraZeneca-SKBio and the Serum Institute of India.

WHO’s declaration is expected to prompt the distribution of hundreds of millions of doses to economies that have joined the UN-backed COVAX initiative aimed at providing vaccines to the most vulnerable people in the world.

It is worth noting that the AstraZeneca vaccine has already been approved in over 50 countries, including Mexico, Argentina, India, and Britain. It is an inexpensive and simple dose to manage as compared to the Pfizer-BioNTech vaccine, which requires deep-cold storage, which is not common in many developing nations, sources claimed.

The use of the AstraZeneca COVID-19 vaccine was recommended by WHO experts, especially for people over the age of 18 years as well as in countries that have found COVID-19 variants.

Sources confirmed that post this development, the shares of the India unit of AstraZeneca Pharma increased by 9.7% to reach a high of USD 54.70 (Rs 3,985) on BSE (Bombay Stock Exchange).

After the Pfizer-BioNTech vaccine was approved in December by the WHO, the AstraZeneca vaccine is just the second approval given by the UN Health Agency.

Meanwhile, Australia has recently approved AstraZeneca’s COVID-19 vaccine and has requested around 53.8 million doses.

Source Credit –

https://economictimes.indiatimes.com/markets/stocks/news/astrazeneca-pharma-surges-10-as-who-okays-covid-vaccine-for-emergency-use/articleshow/80963175.cms

 

 

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

Nintendo to allow users develop custom games using Game Builder Garage
Nintendo to allow users develop custom games using Game Builder Garage
By Pranali Mehta

Japanese multinational video game company Nintendo Co. Ltd. has reportedly launched the ‘Game Builder Garage’, a Switch title that allows users to create their games. The software lets players build games without having to code them and ...

HCL Tech to upgrade Hitachi ABB Power’s IT services infrastructure
HCL Tech to upgrade Hitachi ABB Power’s IT services infrastructure
By Pranali Mehta

The IT major will deliver hybrid cloud services, unified service management, digital workplace services, next-gen network services, and cybersecurity services to Hitachi ABB Power Grids As part of a global transformation program, HCL Technologies ha...

Uber and Arrival announce partnership to build EV for ride-hail drivers
Uber and Arrival announce partnership to build EV for ride-hail drivers
By Pranali Mehta

Arrival Ltd, a U.K based automobile company, and American tech giant Uber have reportedly signed a joint venture agreement to build an electric vehicle (EV) for all Uber’s ride-hail drivers. Arrival plans to release the final EV design before ...